Drugs / GX301
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02293707 | Nov 2014 → Aug 2018 | prostate cancer | Laboratoires Leurquin Mediolanum | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GX301 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02293707 ↗ |
| Modality | Vaccine | “GX301 is an experimental therapeutic vaccine” NCT02293707 ↗ |